首页> 外国专利> CHIRAL DIACYLHYDRAZINE LIGANDS FOR MODULATING EXPRESSION OF EXOGENOUS GENES VIA ECDYSONE RECEPTOR COMPLEX

CHIRAL DIACYLHYDRAZINE LIGANDS FOR MODULATING EXPRESSION OF EXOGENOUS GENES VIA ECDYSONE RECEPTOR COMPLEX

机译:手性二乙酰肼配体,通过蜕皮激素受体复合物调控外源基因的表达

摘要

PROBLEM TO BE SOLVED: To provide diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems.SOLUTION: There is provided a compound represented by formula 1, or a pharmacologically acceptable salt, hydrate, crystalline form or amorphous form thereof. (A is alkoxy, arylalkyloxy or aryloxy; B is optionally substituted aryl or optionally substituted heteroaryl; and R1 and R2 are independently optionally substituted alkyl, arylalkyl, hydroxyalkyl, haloalkyl, cycloalkyl, alkenyl, alkynyl, optionally substituted heterocycle, aryl or heteroaryl.)SELECTED DRAWING: Figure 1
机译:解决的问题:提供二酰基肼配体和手性二酰基肼配体以基于蜕皮激素受体的诱导型基因表达系统使用。解决方案:提供了由式1表示的化合物,或药理学上可接受的盐,水合物,结晶形式或无定形形式其。 (A为烷氧基,芳基烷氧基或芳氧基; B为任选取代的芳基或任选取代的杂芳基; R1和R2独立为任选取代的烷基,芳基烷基,羟烷基,卤代烷基,环烷基,烯基,炔基,任选取代的杂环,芳基或杂芳基。)选定的图纸:图1

著录项

  • 公开/公告号JP2018080189A

    专利类型

  • 公开/公告日2018-05-24

    原文格式PDF

  • 申请/专利权人 INTREXON CORP;

    申请/专利号JP20170249527

  • 发明设计人 ROBERT E HORMANN;LI BING;

    申请日2017-12-26

  • 分类号C07C243/38;C07C241/04;A61K47/44;A61K47/14;A61K47/10;A61P43;A61P35;A61P17;A61K48;A61K35/12;A61K35/761;A61K31/166;A61K31/36;A61K31/357;A61K31/381;A61K31/341;A61K31/44;C07D317/68;C07D319/18;C07D333/38;C07D307/68;C07D213/87;C12N15/09;C12P21/02;C07B53;A61K38/20;

  • 国家 JP

  • 入库时间 2022-08-21 13:13:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号